Back to search results

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

PD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Jun Liu, MD) · jly0520@hotmail.com · 15221303819
    Contact: Study coordinator (Jing Sun, MD) · sunjing2@medmail.com.cn · 13816899762
    Contact: Principal Investigator (Jun Liu, MD)
    Contact: Principal Investigator (Jing Sun, MD)
Study leads

  • Jun Liu, MD

    Principal Investigator

    Ruijin Hospital

  • Jing Sun, MD

    Principal Investigator

    Ruijin Hospital

View source on ClinicalTrials.gov(opens in a new tab)